Maitake for Glucose / insulin sensitivity and Maitake
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
Maitake for Glucose / insulin sensitivity
Evidence grade C — Early
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
Maitake
A culinary-medicinal mushroom with beta-glucan immune activity and early glucose signals.
Grade C2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Maitake for Glucose / insulin sensitivity | Maitake |
|---|---|---|
| Glucose / insulin sensitivity | Evidence grade CSmall effectlowEarly | Evidence grade CSmall effectlowEarly |
Graded only in Maitake for Glucose / insulin sensitivity
None — every outcome it grades is graded in both.
Graded only in Maitake
- Immune modulation Small effectEvidence grade C
What each entry says about the other
- Maitake for Glucose / insulin sensitivity’s entry · Goes with: Read the full Maitake monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.